Redhill Biopharma Ltd.
RDHL
RDHL: Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults, Talicia for the treatment of Helicobacter pylori infection in adults, and Aemcolo for the treatment of travelers' diarrhea in adults. Its key clinical late-stage development programs include RHB-104 for Crohn's disease; RHB-204, for pulmonary nontuberculous mycobacteria infections; RHB-102 (Bekinda) with positive results from a first Phase 3 study for acute gastroenteritis and gastritis; Opaganib (Yeliva); RHB-106, an encapsulated bowel preparation and RHB-107, a Phase 2-stage serine protease inhibitor targeting cancer and inflammatory gastrointestinal diseases.
moreShow RDHL Financials
Recent trades of RDHL by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by RDHL's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Combination compositions for treatment of cancer Apr. 25, 2023
-
Patent Title: Triple antibiotic fixed-dose combination products, dosing regimen, methods, and kits for treating pulmonary non-tuberculosis mycobacterial infections Feb. 28, 2023
-
Patent Title: Sphingosine kinase 2 inhibitor for treating coronavirus infection in moderately severe patients with pneumonia Oct. 18, 2022
-
Patent Title: Sphingosine kinase 2 inhibitor for treating coronavirus infection Jun. 21, 2022
-
Patent Title: Rifabutin-based compositions and methods for treating Oct. 05, 2021
-
Patent Title: Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimine Aug. 17, 2021
-
Patent Title: Compositions for treating ebola virus infection Aug. 17, 2021
-
Patent Title: Formulations and methods of manufacturing formulations for use in colonic evacuation Jul. 13, 2021
-
Patent Title: Sphingosine kinase 2 inhibitor for treating coronavirus infection Jul. 06, 2021
-
Patent Title: Serine protease inhibitor for treating coronavirus infection Jun. 29, 2021
-
Patent Title: Method for treating cancer with combination therapy Mar. 16, 2021
-
Patent Title: Methods for treating helicobacter pylori infection Jan. 26, 2021
-
Patent Title: Method for treating crohn's disease using triple antimicrobial all-in-one formulation Sep. 08, 2020
-
Patent Title: Compositions, methods and kits for treating diarrhea-predominant irritable bowel syndrome Jun. 02, 2020
-
Patent Title: Blister package May. 12, 2020
-
Patent Title: Therapy for inhibition of single-stranded rna virus replication Jan. 28, 2020
-
Patent Title: Formulations and methods of manufacturing formulations for use in colonic evacuation Dec. 03, 2019
-
Patent Title: Combination therapies for treating cancer Nov. 05, 2019
-
Patent Title: Methods of treating a bacterial infection using a fixed-dose pharmaceutical composition comprising three antibiotics Oct. 08, 2019
-
Patent Title: Pharmaceutical compositions for the treatment of Mar. 26, 2019
-
Patent Title: Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimine Dec. 04, 2018
-
Patent Title: Therapy for inhibition of single-stranded rna virus replication May. 22, 2018
-
Patent Title: Composition and method for treating an autoimmune disease Feb. 27, 2018
-
Patent Title: Combination therapies for treating cancer Dec. 19, 2017
-
Patent Title: Ondansetron extended release solid dosage forms for treating either nausea, vomiting or diarrhea symptoms Jun. 13, 2017
-
Patent Title: Antiemetic extended release solid dosage forms May. 02, 2017
-
Patent Title: Pharmaceutical compositions for the treatment of Mar. 28, 2017
-
Patent Title: Pharmaceutical compositions for the treatment of Nov. 22, 2016
-
Patent Title: Compositions comprising rifabutin, clarithromycin, and clofazimine and uses thereof Apr. 19, 2016
-
Patent Title: Methods and compositions comprising rifabutin, clarithromycin, and clofazimine Dec. 01, 2015
-
Patent Title: Methods and compositions for treating inflammatory bowel disease Jul. 07, 2015
-
Patent Title: Pharmaceutical compositions for the treatment of Jun. 09, 2015
Federal grants, loans, and purchases
Followers on RDHL's company Twitter account
Number of mentions of RDHL in WallStreetBets Daily Discussion
Recent insights relating to RDHL
Recent picks made for RDHL stock on CNBC
ETFs with the largest estimated holdings in RDHL
Flights by private jets registered to RDHL